|
|
On The Cover
Breaking Down The Complex
Regardless of the current economic climate and the increasing complexities and costs of drug development, the objective for clinical operations executives remains the same: identify the top people and most advanced technologies, and put both behind drug candidates that show the most promise.
By Carolyn Gretton
Features
You Can’t Teach People to Care or Can You?
Aureus Research Consultants LLC
By Alicia Pouncey, MEd, Aureus Research Consultants LLC
An Albatross and an Opportunity
BioClinica
By Mark Weinstein, BioClinica
Maintaining Clinical Operations in a Downward Economy: It’s Just Good Business
Criterium Inc.
By Lawrence Reiter, Ph.D., Criterium Inc.
Metrics Predict Success for Clinical Trials
i3 Pharma Informatics
By Bill Gwinn, i3 Pharma Informatics
Adapting to Meet Today’s Needs
inVentiv Clinical Solutions
By Stephen O. Cottrell, inVentiv Clinical Solutions
Clinical Monitoring: How EDC Has Changed the Game
Medidata Solutions
Ron Rubinstein, Medidata Solutions and Scott Freedman, Monitorforhire.com
|
|
